Vanderbilt-Ingram website >
Thanks to Vanderbilt-Ingram Cancer Center’s new Clinical Trials Mentor Program, patients considering enrolling in a clinical trial can now ask questions and get first-hand accounts from patient advocates who have already gone through the process.
The Vanderbilt-Ingram Cancer Center has been chosen by the National Cancer Institute to join an elite group of researchers asked to test the most cutting-edge cancer treatments in Phase II clinical trials in both solid tumor and hematologic malignancies.
Researchers at the Vanderbilt-Ingram Cancer Center have uncovered a clue to explain the invasive nature of an aggressive kind of brain tumor called glioblastoma multiforme, or gliomas, and their findings are published in this week’s online edition of the journal Oncogene.
The Vanderbilt-Ingram Cancer Center is leading a multi-institutional effort supported by the National Cancer Institute (NCI) to identify “molecular signatures” of lung cancer.
Cancer patients displaced by Hurricane Katrina and its aftermath who are in Middle Tennessee and Southern Kentucky and in need of continued treatment can contact the Vanderbilt-Ingram Cancer Center for assistance.
The Vanderbilt-Ingram Cancer Center will launch a new research institute, jump-started with a $10 million gift from West Tennessee businessman Jim Ayers, to develop techniques to detect cancers at their earliest, most curable stages, Vanderbilt officials announced today.